Results

Total Results: 2,086 records

Showing results for "developing".

201. Prioritization Criteria Methodology for Future Research Needs Proposals Within the Effective Health Care Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/future-research-prioritization-methods_research.pdf
     January 01, 2013 - literature on topics assigned to them by AHRQ and conduct additional analyses when appropriate prior to developing … preliminary criteria and a model worksheet that EPCs and stakeholders could use when identifying, developing … these high-priority research needs, the EPC will consider the feasibility and capacity criteria when developing

202. BLUEPRINT FOR A FUTURE DISTRIBUTED RESEARCH NETWORK (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-blueprint_research.pdf
     June 01, 2010 - BLUEPRINT FOR A FUTURE DISTRIBUTED RESEARCH NETWORK The DEcIDE (Developing Evidence to Inform … This report is based on research conducted by the DEcIDE (Developing Evidence to Inform Decisions about … including research (e.g., comparing medicines for a specific condition) and data infrastructure (e.g., developing

203. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Risk factors for developing gout include obesity, hypertension, alcohol consumption, diuretic use, … Allopurinol-Refractory Gout  Key Facts: Hyperuricemia is believed to be the most important risk factor for developing … Allopurinol-Refractory Gout Intervention: Hyperuricemia is thought to be the most important risk factor for developing

204. Disposition of Comments for CER 222: Achieving Health Equity in Preventive Services (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-222-health-equity-preventive-services-comments.pdf
     December 03, 2019 - impact the ability of members of these populations to quit smoking and thereby reduce their risk of developing

205. Evidence Summary - Comparative Effectiveness Review No. 249: Malnutrition in Hospitalized Adults: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-249-malnutrition-hospitalized-adults-evidence-summary_0.pdf
     October 01, 2021 - that the Agency for Healthcare Research and Quality (AHRQ) convene a panel of experts charged with developing

206. Evidence Summary - Comparative Effectiveness Review No. 249: Malnutrition in Hospitalized Adults: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-249-malnutrition-hospitalized-adults-evidence-summary.pdf
     October 01, 2021 - that the Agency for Healthcare Research and Quality (AHRQ) convene a panel of experts charged with developing

207. Interventions to Improve Care of Bereaved Persons | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/bereaved-persons/protocol

208. Chronic Kidney Disease Stages 1-3: Screening, Monitoring, and Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_disposition-comments.pdf
     August 01, 2012 - care decisions of primary care physicians and to provide background to material to assist groups developing … that non-caucasian groups, particularly African-Americans and Latinos, have an elevated risk for developing … The risk of developing CKD and ESRD in these groups is likely not explained entirely by the higher … hypertension in these populations.African-Americans, for example, are at disproportionate risk for developing … The risk of developing CKD and ESRD in these groups is likely not explained entirely by the higher

209. Disposition of Comments_Technical Brief No. 45: Long COVID Models of Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-covid-disposition-comments.pdf
     January 01, 2022 - published definitions for long COVID, limitations in current definitions, and considerations for developing … published definitions for long COVID, limitations in current definitions, and considerations for developing … published definitions for long COVID, limitations in current definitions, and considerations for developing … Developing a Model System of Rehabilitation Care for Patients Post-COVID-19. … The report described definitions of long COVID and considerations for developing a new definition.

210. Work Plan for Methods Research on (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-classification_research.pdf
     December 01, 2010 - Work Plan for Methods Research on Methods Research Report Developing and Testing a Tool for … Developing and Testing a Tool for the Classification of Study Designs in Systematic Reviews of Interventions … Top Ranked Classification Tools ES-1 Developing and Testing a Tool for the Classification … Two members of the Steering Committee (LH, KB) who were not involved in developing the reference standard … We consider the results of this study as a contribution to the developing evidence base that may help

211. Pneumonia-Antibiotic-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pneumonia-antibiotic-treatment_executive.pdf
     November 01, 2014 - Some patients may require intubation after developing severe HAP; in these cases, clinicians should … antibiotic stewardship programs to employ to improve antibiotic use.37 In fact, the IDSA guidelines for developing … counts of culture, and development of antibiotic resistance can also yield information useful for developing … Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing

212. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-ovarian-contraceptives_research-protocol.pdf
     March 13, 2012 - presents at a much later stage than other common cancers.1 This in turn has led to intense interest in developing … of OC use (e.g., dose/formulation, age at initiation, duration of use) affect the relative risk of developing … history of breast and ovarian cancer, BRCA1/BRCA2 mutation status, parity) affect the relative risk of developing … In developing this comprehensive overview, we will apply the rules of evidence and formulation of strength

213. Treatment of Dementia Among Community-Dwelling and Institutionalized Medicare Beneficiaries (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-databases-methods_research.pdf
     May 01, 2008 - May 2008 Research from the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Network … The DEcIDE (Developing Evidence to Inform Decisions about Effectiveness) network is part of … This report is based on research conducted by the University of Maryland at Baltimore DEcIDE (Developing … Report to AHRQ DEcIDE (Developing Evidence to Inform Decisions and Effectiveness) Network.

214. Child-Growth-Development-Outcomes-Draft-Report-Rob (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/child-growth-development-outcomes-draft-report-rob.xlsx
     January 01, 2017 - RCT RefID Author, year (Trial/Study Name if applicable) Is randomization adequate? Yes/No/Unclear/NR Is allocation concealment adequate? Yes/No/Unclear/NR Are groups similar at baseline? Yes/No/Unclear/NR Is the outcome assessor (interviewer) masked? Yes/No/Unclear/NR Is the data analyst masked? Yes/No/…

215. Hypertension-Drugs-Utilization Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-drugs-utilization_research.pdf
     January 25, 2011 - Division, University of Pennsylvania School of Medicine, Philadelphia, PA 2 University of Pennsylvania Developing … Department of Health and Human Services, as part of the Developing Evi- dence to Inform Decisions about

216. Research White Paper Multinational Registries Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/multinational-registries-guide-3rd-ed-addendum-white-paper.pdf
     February 01, 2018 - Before developing a new multinational registry, it is useful to consider the feasibility of each model … rates for specific types of cancer as well as for all cancers.27, 28 When planning a registry, developing … ethical, and legal environments in which a multinational study will operate is a critical step in developing … This includes developing recruitment materials that comply with local regulations, are culturally appropriate … At present, sound planning and design, along with proactive risk management, are essential for developing

217. Cancer-Pancreas Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-pancreas_executive.pdf
     September 01, 2014 - Task Force gives a D recommendation).10 However, some recommend screening people at high risk of developing … diagnosis of pancreatic adenocarcinoma • Adult patients without symptoms who are at high risk of having or developing … MDCT and PET/CT use radiation and, therefore, could theoretically increase the risk of developing cancer … When screening individuals at hish risk of developing pancreatic adenocarcinoma, 2 percent to 18 percent … Evaluating practices and developing tools for comparative effectiveness reviews of diagnostic test

218. Elwyn_Presentation_REVISED_FINAL (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/investing_elwyn_presentation.pdf
     January 01, 2009 - www.effectivehealthcare.ahrq.gov/index.cfm)     Slide  1:  Investing  in  deliberation:  defining  and  developing

219. Han (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/han.pdf
     December 26, 2012 - risk estimates: NCI CCRAT Two  bars  illustrating  integrated  textual and  visual risk for developing

220. Research White Paper Biorepositories Addendum Registries For Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/biorepositories-registries-guide-3rd-ed-addendum-white-paper.pdf
     February 01, 2018 - ................................................................................ 10 Challenges in Developing … data with biorepositories has great potential, there are many challenges that must be addressed in developing … planning, operational, as well as regulatory, legal, and ethical issues that should be considered when developing … Each repository will need to consider these specific circumstances when developing procurement procedures … Ethical and Regulatory Considerations Regulatory Considerations Informed Consent Challenges in Developing